Validating drug production processes need not be a headache, according to AI researchers who say machine learning (ML) could be a single answer to biopharma’s multivariate problem. The FDA defines ...
In joint research with the University of Tokyo (UTokyo), the National Institute of Advanced Industrial Science and Technology (AIST), Tohoku University, and Kyoto Institute of Technology, the National ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback